Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/600812 stock hub

SHA/600812 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600812is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600812

In the news

Latest news · SHA/600812

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E55.8

P25 23.5P50 41.3P75 83.2

ROE3.4

P25 -0.9P50 4.1P75 8.8

ROIC2.5

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600812 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

CNY

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	10,000
Employees Change	-88%
Employees Change Percent	-0.87
Enterprise value	CNY 20.2B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE000000D16
Last refreshed	2026-05-10
Market cap	CNY 9B
Price	CNY 5.25
Price currency	CNY
Rev Per Employee	874,362.29x
Sector	Healthcare
Sic	2834
Symbol	sha/600812
Website	https://www.ncpc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.79%
EV Earnings	125.71x
EV/EBIT	34.47x
EV/EBITDA	12.99x
EV/FCF	32.25x
EV/Sales	2.3x
FCF yield	6.97%
P/B ratio	1.3x
P/E ratio	55.76x
P/S ratio	1.02x
PE Ratio10 Y	245.3x
PE Ratio3 Y	308.22x
PE Ratio5 Y	343.38x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.56%
EBITDA Margin	16.91%
FCF margin	7.12%
Gross margin	31.11%
Gross Profit	CNY 2.7B
Gross Profit Growth	-11.86%
Gross Profit Growth Q	-17.75%
Gross Profit Growth3 Y	-7.57%
Gross Profit Growth5 Y	-8.21%
Net Income	CNY 161M
Net Income Growth	-3.18%
Net Income Growth Q	-38.3%
Net Income Growth Years	3%
Pretax Margin	3.63%
Profit Margin	1.83%
Profit Per Employee	CNY 15,963
Profitable Years	3
ROA	1.66
Roa5y	1.72
ROCE	5.78
ROE	3.36
Roe5y	-0.37
ROIC	2.49
Roic5y	2.35

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.82%
Cagr15y	-5.23%
Cagr1y	-12.99%
Cagr20y	5.98%
Cagr3y	-3.87%
Cagr5y	-11.13%
Div CAGR10	4.14%
Div CAGR3	-20.63%
Div CAGR5	0%
EPS Growth	-2.28
EPS Growth Q	-38.24
EPS Growth Years	3
FCF Growth	452.18%
FCF Growth Q	-16.04%
FCF Growth3 Y	1.84%
OCF Growth	41.91%
OCF Growth Q	-2.85%
OCF Growth10 Y	19.99%
OCF Growth3 Y	0.49%
OCF Growth5 Y	9.58%
Revenue Growth	-10.78x
Revenue Growth Q	-16.36x
Revenue Growth Years	0x
Revenue Growth3 Y	-5.99x
Revenue Growth5 Y	-5.79x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.41
Assets	CNY 21.5B
Cash	CNY 1.4B
Current Assets	CNY 8.3B
Current Liabilities	CNY 11.4B
Debt	CNY 11.2B
Debt EBITDA	CNY 7.28
Debt Equity	CNY 1.62
Debt FCF	CNY 17.9
Equity	CNY 6.9B
Interest Coverage	1.6
Liabilities	CNY 14.5B
Long Term Assets	CNY 13.2B
Long Term Liabilities	CNY 3.1B
Net Cash	CNY -9.9B
Net Cash By Market Cap	CNY -109
Net Debt EBITDA	CNY 6.6
Net Debt Equity	CNY 1.42
Net Debt FCF	CNY 15.7
Tangible Book Value	CNY 2.6B
Tangible Book Value Per Share	CNY 1.52
WACC	3.97

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.72
Inventory Turnover	2.53
Net Working Capital	CNY 3.7B
Quick ratio	0.49
Working Capital	CNY -3.2B
Working Capital Turnover	CNY -2.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.92%
Dividend Growth	200%
Dividend Growth Years	1%
Dividend per share	CNY 0.04
Dividend Years	2
Dividend Yield	0.67%
Last Dividend	CNY 0.03
Payout Ratio	257.31%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-16.75%
1Y total return	-12.99%
200-day SMA	5.92
3Y total return	-11.18%
50-day SMA	5.49
50-day SMA vs 200-day SMA	50under200
5Y total return	-44.57%
All Time High	20.24
All Time High Change	-74.06%
All Time High Date	2020-08-06
All Time Low	1.08
All Time Low Change	384.76%
All Time Low Date	1995-07-04
ATR	0.11
Beta	0.32
Beta1y	0.13
Beta2y	0.48
Ch YTD	-5.06
High	5.26
High52	7.46
High52 Date	2025-07-30
High52ch	-29.62%
Low	5.2
Low52	5.01
Low52 Date	2026-03-23
Low52ch	4.79%
Ma50ch	-4.28%
Price vs 200-day SMA	-11.35%
RSI	41.43
RSI Monthly	43.49
RSI Weekly	37.16
Sharpe ratio	-0.6x
Sortino ratio	-0.65
Total Return	1.59%
Tr YTD	-5.06
Tr15y	-55.31%
Tr1m	-6.91%
Tr1w	0.57%
Tr3m	-5.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 578.5M
Operating Income Growth	-16.15
Operating Income Growth Q	-14.24
Operating Income Growth3 Y	-2.65
Operating Income Growth5 Y	3.54
Operating margin	6.56

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	772,029,954%
Net Borrowing	-649,162,365
Shares Insiders	0%
Shares Institutions	9.5%
Shares Out	1,715,730,370
Shares Qo Q	0.87%
Shares Yo Y	-0.92%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 627.7M
Average Volume	18,647,989.55x
Bv Per Share	3.29
CAPEX	CNY -544.2M
Ch10y	-19.72
Ch15y	-57.21
Ch1m	-6.91
Ch1w	0.57
Ch1y	-13.37
Ch20y	205.8
Ch3m	-5.91
Ch3y	-11.76
Ch5y	-45.6
Ch6m	-14.91
Change	0.77%
Change From Open	0.77
Close	5.21
Days Gap	0
Depreciation Amortization	913,469,077
Dollar Volume	54,439,197.8
Earnings Date	2026-04-18
EBIT	CNY 578.5M
EBITDA	CNY 1.5B
EPS	CNY 0.09
F Score	5
FCF	CNY 627.7M
FCF EV Yield	3.1x
FCF Per Share	CNY 0.37
Financing CF	-735,217,030
Fiscal Year End	December
Founded	1,992
Graham Number	2.63821
Graham Upside	-49.75
Income Tax	CNY 90.3M
Investing CF	-843,099,219
Is Primary Listing	1
Last Earnings Date	2026-04-18
Last Report Date	2026-03-31
Last Split Date	2006-08-16
Last Split Type	Forward
Ma150	5.7
Ma150ch	-7.91%
Ma20	5.4
Ma20ch	-2.81%
Net CF	-414,389,304
Next Earnings Date	2026-08-14
Open	5.21
P FCF Ratio	14.35
P OCF Ratio	7.69
Payment Date	2025-07-25
Position In Range	83.33
Ppne	6,740,326,430
Price Date	2026-05-08
Price EBITDA	CNY 6.04
Ptbv Ratio	3.52
Relative Volume	0.56x
Revenue	8,820,566,778x
Tax By Revenue	1.02x
Tax Rate	28.18%
Tr20y	219.42%
Tr6m	-14.91%
Volume	10,369,371

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600812 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$0.04 annual per share

Payout ratio

+257.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

1 consecutive years of growth

Total shareholder yield

+1.6%

Dividend yield + buyback yield combined

Performance

SHA/600812 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600812?

Insider, institutional, and short-interest positioning.

Institutional ownership

+9.5%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.9%

Negative means the company is buying back shares.

Technical

SHA/600812 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.4

Neutral momentum band

Price vs 200-day MA

-11.3%

50/200-day relationship not available

Beta (5Y)

0.32

Less volatile than the market

Sharpe ratio

-0.60

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600812

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600812 stock rating?

sha/600812 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600812 analysis?

The full report lives at /stocks/sha/600812/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600812?

The latest report frames sha/600812 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600812 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.